Daniel Chain is listed as an executive officer and director on 4 SEC Form D filings by 1 issuer between Nov 2020 and Mar 2022: TAUC3 Biologics Ltd (London, United Kingdom (as filed: X0) — biotechnology — 2020–2022; $690K reported sold to 4 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Andrew Heath (4 shared filings), John Gogol (4 shared filings), Parag Saxena (4 shared filings) and Shafique Virani (4 shared filings).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Daniel. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 bankruptcy case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 4 public filings for Daniel Chain and found 6 differences, 1 worth asking the sponsor about: Form D filed 66 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.